FDA's Role in the Opioid Crisis

The chapter explores the FDA's approval process for opioids and its response to criticism amidst the opioid crisis. It discusses the over-prescription and misuse of opioids in treating chronic pain, as well as the flaws in the FDA approval process that have contributed to the deepening crisis. The episode delves into conflicts of interest and unethical practices within the FDA, including the revolving door phenomenon between FDA staff and pharmaceutical companies.